Evidence map›Paper›PMID 39479990›Full record

ArticleJournal of proteome research2024

The Circulating Proteome─Technological Developments, Current Challenges, and Future Trends.

Philipp E Geyer, Daniel Hornburg, Maria Pernemalm, Stefanie M Hauck, Krishnan K Palaniappan, Vincent Albrecht, Laura F Dagley, Robert L Moritz, Xiaobo Yu, Fredrik Edfors and 8 more

Abstract read
In one paragraph

Article in Journal of proteome research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. A Robust Serum Proteomic Signature of the E2 Allele of Apolipoprotein E.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Philipp E GeyerDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.ORCID 0000-0001-7980-4826
Daniel HornburgSeer, Inc., Redwood City, California 94065, United States.ORCID 0000-0002-6618-7774
Maria PernemalmDepartment of Oncology and Pathology/Science for Life Laboratory, Karolinska Institutet, 17177 Stockholm, Sweden.
Stefanie M HauckMetabolomics and Proteomics Core, Helmholtz Zentrum München GmbH, German Research Center for Environmental Health, 85764 Oberschleissheim, Munich, Germany.ORCID 0000-0002-1630-6827
Krishnan K PalaniappanFreenome, South San Francisco, California 94080, United States.ORCID 0000-0003-0203-9016
Vincent AlbrechtDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.
Laura F DagleyThe Walter and Eliza Hall Institute for Medical Research, Parkville, VIC 3052, Australia.ORCID 0000-0003-4171-3712
Robert L MoritzInstitute for Systems Biology, Seattle, Washington 98109, United States.
Xiaobo YuState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing 102206, China.
Fredrik EdforsScience for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology, 17121 Solna, Sweden.
Yves VandenbrouckCEA, Fundamental Research Division, 91191 Gif-sur-Yvette, France.ORCID 0000-0002-1292-373X
Johannes B Mueller-ReifDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.
Zhi SunInstitute for Systems Biology, Seattle, Washington 98109, United States.
Virginie BrunUniversité Grenoble Alpes, CEA, Leti, Clinatec, Inserm UA13 BGE, CNRS FR2048, Grenoble, France.ORCID 0000-0002-9098-8707
Sara AhadiAlkahest, Inc., Suite D San Carlos, California 94070, United States.
Gilbert S OmennInstitute for Systems Biology, Seattle, Washington 98109, United States.ORCID 0000-0002-8976-6074
Eric W DeutschInstitute for Systems Biology, Seattle, Washington 98109, United States.ORCID 0000-0001-8732-0928
Jochen M SchwenkScience for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology, 17121 Solna, Sweden.ORCID 0000-0001-8141-8449

Funding

Systems BiologyU19AG023122 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI Ryan Tewhey · 2004 to 2026
$102.6M
Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Dana Dolinoy · 2011 to 2026
$21.3M
Shortening the development cycle time of Trans Proteomic Pipeline tools with high performance computingR01GM087221 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI DEUTSCH, ERIC, MORITZ, ROBERT L · 2010 to 2021
$6.0M
University of Michigan Proteogenomics Data Analysis CenterU24CA210967 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHINNAIYAN, ARUL M, DHANASEKARAN, SARAVANA M · 2016 to 2020
$4.1M
NCI NIH HHS U24 CA210967NIA NIH HHS U19 AG023122NIEHS NIH HHS P30 ES017885NIGMS NIH HHS R01 GM087221
6 · The paper itself

Abstract

Recent improvements in proteomics technologies have fundamentally altered our capacities to characterize human biology. There is an ever-growing interest in using these novel methods for studying the circulating proteome, as blood offers an accessible window into human health. However, every methodological innovation and analytical progress calls for reassessing our existing approaches and routines to ensure that the new data will add value to the greater biomedical research community and avoid previous errors. As representatives of HUPO's Human Plasma Proteome Project (HPPP), we present our 2024 survey of the current progress in our community, including the latest build of the Human Plasma Proteome PeptideAtlas that now comprises 4608 proteins detected in 113 data sets. We then discuss the updates of established proteomics methods, emerging technologies, and investigations of proteoforms, protein networks, extracellualr vesicles, circulating antibodies and microsamples. Finally, we provide a prospective view of using the current and emerging proteomics tools in studies of circulating proteins.

Indexed as

Blood ProteinsProteomeProteomicsHumansBlood ProteinsProteomeaffinitybiomarker discoverybloodextracellular vesiclemass spectrometrymicrosamplingPeptideAtlasplasmaPTMserum

Identifiers

PMID39479990
PMCPMC11629384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.